170 related articles for article (PubMed ID: 34563111)
1. A novel pN3 gastric cancer staging system with superior prognostic utility based upon the examination of over 31 lymph nodes: a propensity score-matching analysis.
Hu Q; Pan S; Guo Z
BMC Gastroenterol; 2021 Sep; 21(1):352. PubMed ID: 34563111
[TBL] [Abstract][Full Text] [Related]
2. Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study.
MingHua Z; KeCheng Z; ZhenYu C; Lin C; ChunXi W; ZeLong Y
J Gastrointest Surg; 2021 Apr; 25(4):919-925. PubMed ID: 32318943
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of examined lymph node count in older patients with stage T1N0M0 pulmonary carcinoid tumours: a population-based propensity score-matched analysis.
Yang H; Fang Z; Liu T; Zhu X; Luo L
Aging Clin Exp Res; 2023 Jan; 35(1):203-212. PubMed ID: 36319940
[TBL] [Abstract][Full Text] [Related]
4. Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
Dong Y; Qiu Y; Deng J; Wang W; Sun Z; Wang Z; Zhou Z; Xu H; Liang H
J Cancer Res Clin Oncol; 2020 Feb; 146(2):515-528. PubMed ID: 31813005
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis analysis of 310 patients with pathological stage pN3 gastric cancer].
Ke B; Liu N; Liang H; Zhang RP; Wang XJ; Wu LL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):543-6. PubMed ID: 23801207
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the number of examined lymph nodes and the efficacy of chemotherapy for gastric cancer.
Gu L; Chen B; Shen Z; Khadaroo PA; Wang X; Zhu H; Pan J; Zhong X; Mao F; Chen P
Surg Today; 2020 Jun; 50(6):585-596. PubMed ID: 31811459
[TBL] [Abstract][Full Text] [Related]
7. Proposal of a novel subclassification of pN3b for improvement the prognostic discrimination ability of gastric cancer patients.
Wang P; Deng J; Sun Z; Wang W; Wang Z; Xu H; Zhou Z; Liang H
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e20-e26. PubMed ID: 32713746
[TBL] [Abstract][Full Text] [Related]
8. Impact of Removal of Lymph Nodes on Survival in Stage I-III Gastric Signet-Ring Cell Cancer: The More, the Better?
Jiang Y; Shao X; Li W; Hu H; Lu Y; Li Y; Tian Y
Ann Surg Oncol; 2024 Feb; 31(2):783-791. PubMed ID: 37991582
[TBL] [Abstract][Full Text] [Related]
9. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract][Full Text] [Related]
10. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
Yuan SQ; Chen YT; Huang ZP
J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer.
Yang ZL; Zhu MH; Shi Q; Lu FM; Wang CX
J Gastrointest Surg; 2019 Mar; 23(3):460-467. PubMed ID: 30225793
[TBL] [Abstract][Full Text] [Related]
12. Role of Removed Lymph Nodes on the Prognosis of M0 Small-Bowel Neuroendocrine Tumors: a Propensity Score Matching Analysis from SEER Database.
Xie JB; Pang YS; Li X; Wu XT
J Gastrointest Surg; 2021 Dec; 25(12):3188-3197. PubMed ID: 34109533
[TBL] [Abstract][Full Text] [Related]
13. Subclassification of pN3 staging systems for penile cancer: Proposal for modification of the current TNM classification.
Li Z; Guo S; Wu Z; Han H; Li Z; Wang Y; Chen D; Chen J; Deng C; Qin Z; Liu Z; Li Y; Yao K; Zhou F
Urol Oncol; 2017 Sep; 35(9):543.e1-543.e6. PubMed ID: 28578871
[TBL] [Abstract][Full Text] [Related]
14. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation.
Zhang N; Bai H; Deng J; Wang W; Sun Z; Wang Z; Xu H; Zhou Z; Liang H
Ann Transl Med; 2020 Sep; 8(17):1075. PubMed ID: 33145294
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of anatomical extent of metastatic lymph node on gastric cancer: a propensity score matching study.
Cheng LJ; Zhou WJ; An TL; Wei ZW; Yuan C; Xiao X; Hao TF; Yin SC; Zhang CH; He YL
Clin Transl Oncol; 2021 Apr; 23(4):773-782. PubMed ID: 32772226
[TBL] [Abstract][Full Text] [Related]
16. Impact of the number of examined lymph nodes on stage migration in node-negative gastric cancer patients: a Chinese multi-institutional analysis with propensity score matching.
Gu P; Deng J; Wang W; Wang Z; Zhou Z; Xu H; Liang H
Ann Transl Med; 2020 Aug; 8(15):938. PubMed ID: 32953738
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
18. Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?
Yang H; Liu T; Li M; Fang Z; Luo L
Am J Clin Oncol; 2022 Dec; 45(12):506-513. PubMed ID: 36413680
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of N0 Stage with Insufficient Numbers of Lymph Nodes into N1 Stage in the Seventh Edition of the TNM Classification Improves Prediction of Prognosis in Gastric Cancer: Results of a Single-Institution Study of 1258 Chinese Patients.
Li B; Li Y; Wang W; Qiu H; Seeruttun SR; Fang C; Chen Y; Liang Y; Li W; Chen Y; Sun X; Guan Y; Zhan Y; Zhou Z
Ann Surg Oncol; 2016 Jan; 23(1):142-8. PubMed ID: 25986866
[TBL] [Abstract][Full Text] [Related]
20. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]